Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Smadja

Blood

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Blood|October 27, 2023
Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial heartsAngelo Nascimbene, David Bark, David M Smadja
Blood|October 16, 2016
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics studyMaria Bruzelius, Maria Jesus Iglesias, Mun-Gwan Hong, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Blood|October 27, 2023
Hemocompatibility and biophysical interface of left ventricular assist devices and total artificial heartsAngelo Nascimbene, David Bark, David M Smadja
Blood|October 16, 2016
PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics studyMaria Bruzelius, Maria Jesus Iglesias, Mun-Gwan Hong, et al.
Blood|August 14, 2025
Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism SubtypesGaëlle Munsch, Florian Thibord, Ohanna C Bezerra, et al.
Pageof 1